John Snisarenko - Net Worth and Insider Trading
John Snisarenko Net Worth
The estimated net worth of John Snisarenko is at least $133,590 dollars as of 2024-12-25. John Snisarenko is the Chief Commercial Officer of Oyster Point Pharma Inc and owns about 7,000 shares of Oyster Point Pharma Inc (OYST) stock worth over $78,190. John Snisarenko is also the Director of Alimera Sciences Inc and owns about 10,000 shares of Alimera Sciences Inc (ALIM) stock worth over $55,400. Details can be seen in John Snisarenko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Snisarenko has not made any transactions after 2020-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Snisarenko
John Snisarenko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Snisarenko owns 2 companies in total, including Oyster Point Pharma Inc (OYST) , and Alimera Sciences Inc (ALIM) .
Click here to see the complete history of John Snisarenko’s form 4 insider trades.
Insider Ownership Summary of John Snisarenko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OYST | Oyster Point Pharma Inc | 2020-08-10 | Chief Commercial Officer |
| ALIM | Alimera Sciences Inc | 2023-10-02 | director |
John Snisarenko Latest Holdings Summary
John Snisarenko currently owns a total of 2 stocks. Among these stocks, John Snisarenko owns 7,000 shares of Oyster Point Pharma Inc (OYST) as of August 10, 2020, with a value of $78,190 and a weighting of 58.53%. John Snisarenko also owns 10,000 shares of Alimera Sciences Inc (ALIM) as of November 21, 2019, with a value of $55,400 and a weighting of 41.47%.
Latest Holdings of John Snisarenko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OYST | Oyster Point Pharma Inc | 2020-08-10 | 7,000 | 11.17 | 78,190 |
| ALIM | Alimera Sciences Inc | 2019-11-21 | 10,000 | 5.54 | 55,400 |
Holding Weightings of John Snisarenko
John Snisarenko Form 4 Trading Tracker
According to the SEC Form 4 filings, John Snisarenko has made a total of 1 transactions in Oyster Point Pharma Inc (OYST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oyster Point Pharma Inc is the acquisition of 4,000 shares on August 10, 2020, which cost John Snisarenko around $103,880.
According to the SEC Form 4 filings, John Snisarenko has made a total of 0 transactions in Alimera Sciences Inc (ALIM) over the past 5 years. The most-recent trade in Alimera Sciences Inc is the acquisition of 10,000 shares on November 21, 2019, which cost John Snisarenko around $49,500.
Insider Trading History of John Snisarenko
- 1
John Snisarenko Trading Performance
GuruFocus tracks the stock performance after each of John Snisarenko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Snisarenko is 36.75%. GuruFocus also compares John Snisarenko's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Snisarenko within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Snisarenko's insider trading performs compared to the benchmark.
Performance of John Snisarenko
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.04 | | | | | |
| Relative Return to S&P 500(%) | 9.61 | | | | | |
John Snisarenko Ownership Network
John Snisarenko Owned Company Details
What does Oyster Point Pharma Inc do?
Who are the key executives at Oyster Point Pharma Inc?
John Snisarenko is the Chief Commercial Officer of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and director & 10 percent owner Invopps Gp Iv, L.l.c. .
Oyster Point Pharma Inc (OYST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oyster Point Pharma Inc Insider Transactions
John Snisarenko Mailing Address
Above is the net worth, insider trading, and ownership report for John Snisarenko. You might contact John Snisarenko via mailing address: C/o Alimera Sciences, Inc., 6120 Windward Parkway, Suite 290, Alpharetta Ga 30005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
